Alzheimer choir

Posted on by

Alzheimer; News from the web:

HERE is a great initiative!

“Once you get the diagnosis [of Alzheimer’s], you’re identified as either the patient or the caregiver. You start to feel less like spouses,” said Tom Allen, who takes a half-day of vacation on Wednesdays so he can attend the rehearsals at the MacPhail Center for Music in downtown Minneapolis. “In this environment, we’re husband and wife. This is one of the few things that we can still do as a couple. … We love this choir.”

Read all about it HERE

Alzheimer on the road

Posted on by

Alzheimer; News from the web:

Women who find it difficult to think and move at the same time, an ability required to perform everyday tasks such as driving a car are at a higher risk of contracting Alzheimer’s disease, suggests a new study.

The researchers at York University in Canada found a link between performance in such tasks and a communication problem between different brain regions that promote simultaneous thinking and moving.

The study, focused on women, was published in the Journal of Alzheimer’s Disease.

Read all about it HERE

Posted on by

Alzheimer; News from the web:

A clever new analysis has found that during his two terms in office, subtle changes in Mr. Reagan’s speaking patterns linked to the onset of dementia were apparent years before doctors diagnosed hisAlzheimer’s disease in 1994.

Read all about it HERE

Alzheimer musical

Posted on by

Alzheimer; News from the web:

Developed in partnership with Jeffrey Steiger, a pioneer of applied theater, who wrote the original book, music and lyrics, as well as directs Tangles, a musical play and educational outreach initiative concerning cognitive impairment.

Read all about it HERE

A reversal of brain damage caused by Alzheimer

Posted on by

Alzheimer; News from the web:

More news on the great trial from Biogen:

A new Alzheimer’s drug that reverses the damage the disease causes in patients’ brains could ‘change the landscape’ of future treatment, according to researchers.

It has already performed so well at early-stage trials involving people living with the disease in the United States that scientists are now in talks aimed at leapfrogging the usual second stage and fast-tracking it for larger trials.

Pharmaceutical firm Biogen, which developed the drug, called aduncanumab, wants to recruit at least 1,000 patients for tests by the end of the year.

Read all about it HERE